Clinical proof of concept for a safe and effective NF-κB-targeting strategy in multiple myeloma
File(s)Tornatore et al 2018 - BJH -Letter - Revised v2.docx (109.12 KB)
Accepted version
Author(s)
Type
Journal Article
Date Issued
2019-05-01
Date Acceptance
2018-07-19
Citation
British Journal of Haematology, 2019, 185 (3), pp.588-592
ISSN
1365-2141
Publisher
Wiley
Start Page
588
End Page
592
Journal / Book Title
British Journal of Haematology
Volume
185
Issue
3
Copyright Statement
© 2018 British Society for Haematology and John Wiley & Sons Ltd. This is the peer reviewed version of the following article, which has been published in final form at https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.15569. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/30255568
Subjects
NF-κB
apoptosis
clinical trials
drug
multiple myeloma
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2018-09-26